Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Blocking the KATP channel may help treat migraines.

TRPV4 slows hair growth by affecting hair follicle cells.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Some dibenzo compounds might help treat cancer with fewer side effects.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Certain drugs can block changes in brain receptors caused by alcohol withdrawal.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Vitamin D receptor helps prevent skin tumors.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Blocking a protein called prostaglandin D2 might help treat hair loss.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Pranlukast and mirabegron may work as new diabetes drugs.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

A mutation in the VDR gene affects hair cycling without needing ligand binding.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Spanlastic nano-vesicles improve famotidine's effectiveness and absorption.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.